2026-05-15T07:14:43+00:00 2025-06-30 135381590 BDO USA 450 S ORANGE AVE STE 550 ORLANDO FL 328013308 990 2024-07-01 650585415 ALPHA-1 FOUNDATION INC ALPH 3055679888 3300 PONCE DE LEON BLVD CORAL GABLES FL 331347211 SCOTT SANTARELLA PRESIDENT AND CEO 3055679888 2026-05-15 true true SAMANTHA BOKORI P01057347 4078416930 2026-05-13 2024 2025-03-06 01:10:19Z SCOTT SANTARELLA 3300 PONCE DE LEON BLVD CORAL GABLES FL 331347211 26580492 false X ALPHA1.ORG X 1995 FL THE ALPHA-1 FOUNDATION IS COMMITTED TO FINDING A CURE FOR ALPHA-1 ANTITRYPSIN DEFICIENCY AND TO IMPROVING THE LIVES OF ALPHAS WORLDWIDE. 11 11 23 300 329000 0 8897971 10167916 373667 329000 2181265 3211865 161477 46646 11614380 13755427 3230157 3199012 0 0 2245923 2627386 0 0 1124911 4616956 8154384 10093036 13980782 1521344 -225355 44464081 47454771 2581193 3427861 41882888 44026910 X THE ALPHA-1 FOUNDATION IS COMMITTED TO FINDING A CURE FOR ALPHA-1 ANTITRYPSIN DEFICIENCY AND TO IMPROVING THE LIVES OF PEOPLE AFFECTED BY ALPHA-1 WORLDWIDE. false false 5839029 2950012 0 ALPHA-1 RESEARCH NETWORK: THE ALPHA-1 RESEARCH INFRASTRUCTURE PROVIDES SUPPORT FOR A NETWORK OF ALPHA-1 INVESTIGATORS WORLDWIDE. IT IS ONE OF THE FOUNDATION'S MOST VALUABLE ASSETS AND INCLUDES THE DNA & TISSUE BANK, THERAPEUTIC DEVELOPMENT NETWORK, AND CLINICAL RESOURCE CENTERS. THE FOUNDATION'S MISSION IS SERVED BY SCIENTIFIC MEETINGS THAT BRING TOGETHER STAKEHOLDERS WITH THE INTENT TO PROMOTE SCIENTIFIC DISCOVERY, IDENTIFY NEW APPROACHES TO THE DETECTION OF ALPHA-1, AND EDUCATE PHYSICIANS AND PATIENTS ON ALPHA-1. THE ALPHA-1 GRANTS AND AWARDS PROGRAM IS THE HEART OF THE FOUNDATION'S RESEARCH ACTIVITIES AND HAS ESTABLISHED ITSELF AS THE WORLDWIDE LEADER OF ALPHA-1 RESEARCH SUPPORT. 1305234 0 0 ALPHA-1 NATIONAL CONFERENCE: THE 34TH ANNUAL ALPHA-1 NATIONAL EDUCATIONAL CONFERENCE WAS HELD ON JUNE 6-8, 2025. AS THE LARGEST ANNUAL GATHERING OF THE ALPHA-1 COMMUNITY, THE NATIONAL CONFERENCE PROVIDES IMPORTANT OPPORTUNITIES FOR NETWORKING, EDUCATION, AND ADVOCACY. THE SPEAKERS INCLUDED SOME OF THE LEADING CLINICIANS AND RESEARCHERS IN THE ALPHA-1 FIELD TO BRING INCREDIBLE SUBJECT MATTER EXPERTISE AND EDUCATION TO THE COMMUNITY. THE PROGRAM COVERED A WIDE RANGE OF MEDICAL EDUCATION AND SUPPORTIVE TOPICS TO INFORM, EMPOWER AND MOTIVATE PATIENTS TO TAKE CHARGE OF THEIR HEALTH. THE LAST SIX YEARS OF PRESENTATIONS ARE AVAILABLE ON THE FOUNDATION'S WEBSITE AT WWW.ALPHA1.ORG. 641781 249000 0 ALPHA-1 REGISTRY AND ACT STUDY: THE RESEARCH REGISTRY IS A CONFIDENTIAL DATABASE OF DIAGNOSED ALPHAS AND CARRIERS WILLING AND ABLE TO PARTICIPATE IN RESEARCH STUDIES AND CLINICAL TRIALS FOR NEW THERAPIES. IT IS COMPRISED OF BOTH PATIENT SUPPORTED AND CLINICAL DATA. THE REGISTRY REPRESENTS THE LARGEST COHORT OF ALPHAS IN THE WORLD. THE GOAL OF THE ALPHA-1 CODED TESTING (ACT) STUDY IS TO PROVIDE A WAY FOR THOSE AT RISK, INCLUDING FAMILY MEMBERS OF DIAGNOSED ALPHAS, TO LEARN THEIR GENOTYPE. THE STUDY INCLUDES A RESEARCH QUESTIONNAIRE, A FINGERSTICK TESTING KIT, AND IS FREE AND CONFIDENTIAL. 526408 0 0 ALPHA-1 EDUCATION DAYS PROVIDE ACCESS TO CURRENT MEDICAL INFORMATION AND RESOURCES TO HUNDREDS OF ALPHAS, THEIR FAMILIES, AND CAREGIVERS. 2435566 0 0 OTHER ALPHA-1 SERVICES INCLUDE PATIENT EDUCATION (MATERIALS, WEBSITE, ETC), A PATIENT SUPPORT NETWORK, AND A TARGETED DETECTION PROGRAM. 411454 0 0 THE MISSION OF ALPHA-1 GLOBAL IS TO DEVELOP A COLLABORATIVE GLOBAL NETWORK OF ALPHA-1 PATIENT LEADERS, PHYSICIANS, AND RESEARCHERS. 349323 0 0 THE ALPHA-1-TO-ONE MAGAZINE IS DESIGNED TO INFORM THE COMMUNITY OF RESEARCH DEVELOPMENTS, EDUCATION, ADVOCACY AND FUNDRAISING OPPORTUNITIES. 281906 0 0 THE FOUNDATION'S PUBLIC POLICY PROGRAM MONITORS RELEVANT LEGISLATION AND REGULATORY ISSUES AND PUBLICIZES THE FOUNDATION'S POSITIONS ON SUCH ISSUES. 4004657 11790701 true true false true false true false false false false true false false false false true false true false false true true false false true false false true false true false false false false false false false false false false false false false false true true true false false false true 48 0 true 23 true true true false false false false true true false false false false false false X 11 11 false false false false false false false true true false false false true true true true true true true false false false CA FL GA AL HI IL KS KY MD MA MI MN MS MO NH NJ NY NC ND OR PA AZ RI SC TN UT VA WV WI X MARK DELVAUX 3055679888 3300 PONCE DE LEON BLVD CORAL GABLES FL 33134 CATHERINE VERNON DIRECTOR/SECRETARY (AS OF 10/2024) 4.0 0 X X 0 0 0 FRED C WALSH VICE CHAIR (THRU 9/2024) 8.0 0 X X 0 0 0 JON HAGSTROM CHAIR 8.0 0 X X 0 0 0 KENNETH IRVINE TREASURER 8.0 0 X X 0 0 0 PEGGY IVERSON SECRETARY (THRU 10/2024)/VICE CHAIR (AS OF 10/2024) 8.0 0 X X 0 0 0 VIRGINIA CLARK PHYSICIAN DIRECTOR 8.0 0 X X 0 0 0 ALICE TURNER DIRECTOR (AS OF 7/2024) 4.0 0 X 0 0 0 ANN KNEBEL DIRECTOR 4.0 0 X 0 0 0 DARRELL KOTTON DIRECTOR 4.0 0 X 0 0 0 ERIN CARR DIRECTOR (AS OF 7/2024) 4.0 0 X 0 0 0 JENNIFER JOPP DIRECTOR 4.0 0 X 0 0 0 MARK BRANTLY DIRECTOR 4.0 0 X 0 0 0 MARK B DELVAUX CFO 10.0 0 X 100000 0 0 SCOTT SANTARELLA PRESIDENT AND CEO 40.0 0 X 352414 0 25089 ADRIANA ARCE SEN DIRECTOR OF EXECUTIVE OPERATIONS & SCIENTIFIC EVENTS 40.0 0 X 107310 0 17264 ANGELA T MCBRIDE SENIOR DIRECTOR OF CORPORATE RELATIONS 40.0 0 X 135996 0 21725 JEANNE KUSHNER SENIOR DIRECTOR OF COMMUNICATIONS 40.0 0 X 110591 0 29808 LINDA RODRIGUEZ SENIOR DEVELOPMENT DIRECTOR 40.0 0 X 136689 0 3028 RANDEL H PLANT SENIOR DIRECTOR OF RESEARCH PROGRAMS 40.0 0 X 158473 0 22920 1101473 0 119834 6 false true true STRATISHIFT CONSULTING LLC 4521 COTTENDALE DRIVE DURHAM NC 27703 CONSULTING 601371 CROWELL & MORING LLP TWO MANHATTAN WEST 375 NINTH AVENUE NEW YORK NY 10001 LEGAL SERVICES 388479 SIGHT & SOUND PRODUCTIONS LLC 3636 BEACHWOOD COURT JACKSONVILLE FL 32224 VIDEO PRODUCTION 350747 ALPHANET INC 3300 PONCE DE LEON BLVD CORAL GABLES FL 33134 MANAGEMENT SERVICES 344699 EDWARDS-HUNT GROUP LLC 6590 PENDRY AVENUE BOCA RATON FL 33433 CONSULTING SERVICES 303664 8 165000 10002916 8217 10167916 PUBLICATION INCOME 513120 329000 329000 0 0 0 0 329000 974384 974384 6844 6844 0 6844 6844 14979973 12742492 2237481 0 2237481 2237481 122375 165000 82573 39802 39802 0 0 0 0 0 13755427 0 329000 3258511 X 1900825 1900825 1298187 1298187 477503 288554 111786 77163 1699523 1286543 54289 358691 49629 39193 1211 9225 255891 208673 6250 40968 144840 108907 5371 30562 551369 551369 0 0 547398 511397 32346 3655 95093 0 95093 0 86750 86750 0 0 188939 0 188939 0 2752874 2472460 175984 104430 925432 698171 85228 142033 65425 55189 1334 8902 11819 9263 353 2203 469748 380165 66527 23056 2207184 1818631 191459 197094 4707 0 4707 0 38604 30227 1158 7219 DUES AND SUBSCRIPTIONS 139134 39051 24872 75211 LICENSES, FEES AND TAXES 60795 0 17992 42803 REPAIRS AND MAINTENANCE 9113 7146 271 1696 0 0 0 0 13980782 11790701 1065170 1124911 992958 1634327 1052795 1112805 921723 498946 0 0 0 0 195920 166217 565812 418074 10705 147738 39774063 42752962 0 1490917 1116776 25000 25000 44464081 47454771 1000326 1418198 941034 1193830 639833 815833 0 0 0 0 2581193 3427861 X 39896406 41418273 1986482 2608637 41882888 44026910 44464081 47454771 X -225355 2743518 0 0 0 -374141 X false true true false X 7939893 9050130 8383940 8872661 10167916 44414540 0 0 7939893 9050130 8383940 8872661 10167916 44414540 30271246 14143294 469516 474423 690915 939909 981228 3555991 62038 137860 86623 95763 0 382284 0 0 0 0 0 0 48352815 0 0.29250 0.2217 X Schedule A, Part II, Line 17a THE ALPHA-1 FOUNDATION MAINTAINS AN ONGOING SOLICITATION PROGRAM FROM THE GENERAL PUBLIC. DURING THE FISCAL YEAR ENDED JUNE 30, 2025, THE FOUNDATION RECEIVED CONTRIBUTIONS FROM 3,148 DONORS FROM ACROSS THE UNITED STATES. AS SHOWN ON SCHEDULE B, 48 DONORS CONTRIBUTED AMOUNTS OF $5,000 OR HIGHER. FUNDRAISING ACTIVITIES INCLUDE A GENERAL CAMPAIGN, SPECIAL EVENTS, AND OTHER FUNDRAISING APPEALS. THE PUBLIC SUPPORT PERCENTAGE FOR FISCAL 2025 WOULD BE ABOVE 33 1/3% IF THE SUPPORT RECEIVED FROM ALPHANET INC., A SECTION 509(A)(2) PUBLIC CHARITY, WAS EXCLUDED FROM THIS COMPUTATION. THE SUPPORT RECEIVED FROM ALPHANET HAS PROVIDED FUNDING TO SUPPORT DETECTION OF ALPHA-1 AFFECTED PERSONS, RESEARCH FOR IMPROVED THERAPIES, AND A CURE FOR ALPHA-1. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 5750 81000 86750 11703951 11790701 739535 0 184884 0 0 468710 504166 664350 739535 2376761 3565142 10000 10000 61500 86750 168250 117178 126042 166088 184884 594192 891288 10000 10000 6500 5750 32250 1 0 0 0 0 0 28369 0 true true 200825 200825 0 304928 157190 147738 60059 60059 0 147738 0 X 0 0 0 0 0 0 0 0 0 0 0 0 Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote THE FOUNDATION HAS ADOPTED THE PROVISIONS OF FINANCIAL ACCOUNTING STANDARDS CODIFICATION (ASC) 740, INCOME TAXES. UNDER ASC 740, THE FOUNDATION MUST RECOGNIZE THE TAX BENEFIT ASSOCIATED WITH TAX POSITIONS TAKEN FOR TAX RETURN PURPOSES WHEN IT IS MORE LIKELY THAN NOT THAT THE POSITION WILL BE SUSTAINED. MANAGEMENT OF THE FOUNDATION DOES NOT BELIEVE THERE ARE ANY MATERIAL UNCERTAIN TAX POSITIONS AND, ACCORDINGLY, HAS NOT RECORDED ANY LIABILITY FOR UNRECOGNIZED TAX BENEFITS. true North America (Canada & Mexico only) 0 0 Grantmaking 200000 East Asia and the Pacific 0 0 Grantmaking 73812 Europe (Including Iceland and Greenland) 0 0 Grantmaking 1024375 0 0 0 0 0 0 1298187 0 1298187 Europe (Including Iceland and Greenland) RESEARCH 191232 WIRE North America (Canada & Mexico only) RESEARCH 200000 WIRE Europe (Including Iceland and Greenland) RESEARCH 37228 WIRE Europe (Including Iceland and Greenland) RESEARCH 20000 WIRE Europe (Including Iceland and Greenland) RESEARCH 180292 WIRE East Asia and the Pacific RESEARCH 73812 WIRE Europe (Including Iceland and Greenland) RESEARCH 74625 WIRE Europe (Including Iceland and Greenland) RESEARCH 124307 WIRE Europe (Including Iceland and Greenland) RESEARCH 68375 WIRE Europe (Including Iceland and Greenland) RESEARCH 136255 WIRE Europe (Including Iceland and Greenland) RESEARCH 99447 WIRE Europe (Including Iceland and Greenland) RESEARCH 74000 WIRE Europe (Including Iceland and Greenland) RESEARCH 18614 WIRE 13 0 false false false false false false Schedule F, Part I, Line 2 Procedures for monitoring use of grant funds THE FOUNDATION HAS A GRANTS ADVISORY COMMITTEE CONSISTING OF 25 MEMBERS AND 2 STAFF MEMBERS ASSIGNED TO THE COMMITTEE. THE MEMBERSHIP OF THE COMMITTEE CONSISTS OF MEDICAL DOCTORS WHO ARE ALPHA-1 EXPERTS AND RESEARCHERS. THE COMMITTEE REVIEWS GRANT APPLICATIONS FOR QUALITY AND APPLICABILITY OF RESEARCH FUNDS. PRIOR TO ACCEPTANCE, THE PROSPECTIVE GRANTEE IS CHECKED AGAINST THE US TREASURY'S OFAC LIST. ON A QUARTERLY BASIS, ALL GRANTS ARE PEER-REVIEWED FOR PROGRESS BEFORE SUBSEQUENT PAYMENTS ARE MADE. FINAL RESEARCH REPORTS ARE SUBMITTED AND PEER-REVIEWED BEFORE FINAL GRANT PAYMENTS ARE MADE. Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements EAST ASIA AND THE PACIFIC-Cash; EUROPE (INCLUDING ICELAND AND GREENLAND)-Cash; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual Schedule F, Part II, Line 1 Method used to account for expenditures on org's financial statements EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual BUILDING FRIENDS FOR A CURE 287375 165000 122375 68760 6205 7608 0 0 287375 165000 122375 68760 6205 7608 82573 39802 true UNIVERSITY OF FLORIDA 1600 SW ARCHER RD GAINSVILLE FL 32610 596002052 501(C)(3) 470549 RESEARCH REGENTS OF THE UNIV OF CALIFORNIA 1850 RESEARCH PARK DR DAVIS CA 956186153 946036494 501(C)(3) 178944 RESEARCH BRIGHAM & WOMEN'S HOSPITAL INC 75 FRANCIS ST BOSTON MA 02115 042312909 501(C)(3) 174125 RESEARCH BAYLOR COLLEGE OF MEDICINE PO BOX 201361 HOUSTON TX 77216 741613878 501(C)(3) 174051 RESEARCH NATIONAL JEWISH HEALTH 1400 JACKSON ST M217 DENVER CO 80206 742044647 501(C)(3) 99723 RESEARCH UNIVERISTY OF CINCINNATI 4100 WEST 150TH ST CLEVELAND OH 441351304 316000989 501(C)(3) 99500 RESEARCH CLEMSON UNIVERSITY 391 COLLEGE AVE STE 303 CLEMSON SC 39634 576000254 501(C)(3) 99452 RESEARCH BOSTON MEDICAL CENTER 600 HARRISON AVENUE BOSTON MA 02118 043314093 501(C)(3) 95267 RESEARCH THE UNIVERSITY OF TEXAS PO BOX 7159 AUSTIN TX 77137 746000203 501(C)(3) 74000 RESEARCH BOSTON UNIV OF INTERNAL MEDICINE 85 E NEWTON ST M-921 BOSTON MA 021182308 510172171 501(C)(3) 63368 RESEARCH UNIVERSITY OF COLORADO 1600 BROADWAY DENVER CO 80202 846000555 501(c)(3) 52500 RESEARCH UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE INC 3901 RAINBOW BLVD MS 1039 KANSAS CITY KS 66160 480680117 501(C)(3) 48012 RESEARCH UNIVERSITY OF CHICAGO 5801 SOUTH ELLIS AVENUE CHICAGO IL 60637 362177139 501(C)(3) 45894 RESEARCH CENTER FOR VETERANS RESEARCH AND EDUCATION 1 VETERANS DR 151 MINNEAPOLIS MN 55417 411652941 501(C)(3) 38837 RESEARCH TRUSTEES OF BOSTON UNIVERSITY 25 BUICK STREET 2ND FLOOR BOSTON MA 02215 042103547 501(C)(3) 37250 RESEARCH COLUMBIA UNIVERSITY 630 W 168T ST STE 39 NEW YORK NY 10027 135598093 501(C)(3) 35845 RESEARCH UNIVERSITY OF UTAH 201 SOUTH PRESIDENTS CIRCLE RM 159 SALT LAKE CITY UT 84112 876000525 501(C)(3) 10499 RESEARCH FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY 9650 ROCKVILLE PIKE BETHESDA MD 20814 520700497 501(C)(3) 7500 RESEARCH GORDON RESEARCH CONFERENCES 1400 JACKSON ST DENVER CO 80206 260150662 501(C)(3) 7500 RESEARCH 19 0 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds THE FOUNDATION HAS A GRANTS ADVISORY COMMITTEE CONSISTING OF 25 MEMBERS AND 2 STAFF MEMBERS ASSIGNED TO THE COMMITTEE. THE MEMBERSHIP OF THE COMMITTEE CONSISTS OF MEDICAL DOCTORS WHO ARE ALPHA-1 EXPERTS AND RESEARCHERS. THE COMMITTEE REVIEWS GRANT APPLICATIONS FOR QUALITY AND APPLICABILITY OF RESEARCH FUNDS. PRIOR TO ACCEPTANCE, THE PROSPECTIVE GRANTEE IS CHECKED AGAINST THE US TREASURY'S OFAC LIST. ON A QUARTERLY BASIS, ALL GRANTS ARE PEER-REVIEWED FOR PROGRESS BEFORE SUBSEQUENT PAYMENTS ARE MADE. FINAL RESEARCH REPORTS ARE SUBMITTED AND PEER-REVIEWED BEFORE FINAL GRANT PAYMENTS ARE MADE. X X X X X X false false false false false false false false false MARK B DELVAUX CFO 100000 0 0 0 0 0 0 0 0 0 100000 0 0 0 SCOTT SANTARELLA PRESIDENT AND CEO 352414 0 0 0 0 0 10350 0 14739 0 377503 0 0 0 ANGELA T MCBRIDE SENIOR DIRECTOR OF CORPORATE RELATIONS 135996 0 0 0 0 0 7466 0 14259 0 157721 0 0 0 RANDEL H PLANT SENIOR DIRECTOR OF RESEARCH PROGRAMS 158473 0 0 0 0 0 8772 0 14148 0 181393 0 0 0 Schedule J, Part II COMPENSATION FROM AN UNRELATED ORGANIZATION OR INDIVIDUAL NAME - MARK B. DELVAUX, COMPENSATION FROM UNRELATED ORGANIZATION - 100000, NAME OF UNRELATED ORGANIZATION - ALPHANET INC., TYPE OF COMPENSATION - ADMINISTRATIVE SERVICES AGREEMENT Form 990, Part III, Line 4d Description of other program services (Expenses $ 526,408 including grants of $ 0)(Revenue $ 0) ALPHA-1 EDUCATION DAYS PROVIDE ACCESS TO CURRENT MEDICAL INFORMATION AND RESOURCES TO HUNDREDS OF ALPHAS, THEIR FAMILIES, AND CAREGIVERS. Form 990, Part III, Line 4d Description of other program services (Expenses $ 2,435,566 including grants of $ 0)(Revenue $ 0) OTHER ALPHA-1 SERVICES INCLUDE PATIENT EDUCATION (MATERIALS, WEBSITE, ETC), A PATIENT SUPPORT NETWORK, AND A TARGETED DETECTION PROGRAM. Form 990, Part III, Line 4d Description of other program services (Expenses $ 411,454 including grants of $ 0)(Revenue $ 0) THE MISSION OF ALPHA-1 GLOBAL IS TO DEVELOP A COLLABORATIVE GLOBAL NETWORK OF ALPHA-1 PATIENT LEADERS, PHYSICIANS, AND RESEARCHERS. Form 990, Part III, Line 4d Description of other program services (Expenses $ 349,323 including grants of $ 0)(Revenue $ 0) THE ALPHA-1-TO-ONE MAGAZINE IS DESIGNED TO INFORM THE COMMUNITY OF RESEARCH DEVELOPMENTS, EDUCATION, ADVOCACY AND FUNDRAISING OPPORTUNITIES. Form 990, Part III, Line 4d Description of other program services (Expenses $ 281,906 including grants of $ 0)(Revenue $ 0) THE FOUNDATION'S PUBLIC POLICY PROGRAM MONITORS RELEVANT LEGISLATION AND REGULATORY ISSUES AND PUBLICIZES THE FOUNDATION'S POSITIONS ON SUCH ISSUES. Form 990, Part VI, Line 11b Review of form 990 by governing body THE FORM 990 IS PROVIDED TO MEMBERS OF MANAGEMENT AND THE BOARD OF DIRECTORS FOR REVIEW PRIOR TO FILING. Form 990, Part VI, Line 12c Conflict of interest policy WRITTEN CONFLICT OF INTEREST STATEMENTS ARE OBTAINED FROM ALL OFFICERS, BOARD MEMBERS, AND COMMITTEE MEMBERS ON AN ANNUAL BASIS. Form 990, Part VI, Line 15a Process to establish compensation of top management official COMPENSATION LEVELS ARE DEVELOPED USING SALARY SURVEYS AND A REVIEW OF 990S FOR COMPARABLE NOT-FOR-PROFIT ORGANIZATIONS. Form 990, Part VI, Line 19 Required documents available to the public AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON WWW.ALPHA1.ORG. GOVERNING DOCUMENTS AND THE CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. Form 990, Part IX, Line 11g Other Fees OTHER CONTRACT SERVICES - Total Expense: 2752874, Program Service Expense: 2472460, Management and General Expenses: 175984, Fundraising Expenses: 104430; Form 990, Part XI, Line 9 Other changes in net assets or fund balances CHANGES ATTRIBUTED TO INCOME FROM AFFILIATE - -374141; Total - -374141; ALPHA DETECT LLC 3300 PONCE DE LEON BLVD CORAL GABLES FL 331347211 DETECTING RISK OF ALPHA-1 ANTITRYPSIN DEFICIENCY (AATD) DE 750000 750000 ALPHA-1 FOUNDATION INC THE ALPHA-1 PROJECT INC 3300 PONCE DE LEON BLVD CORAL GABLES FL 331347211 272040293 DRUG THERAPIES DE ALPHA-1 FOUNDATION INC C Corporation 18 true false false false false false false false false false false false false false false false false false false false